TY - JOUR T1 - A non-canonical chemical feedback self-limits nitric oxide-cyclic GMP signaling in health and disease JF - bioRxiv DO - 10.1101/383208 SP - 383208 AU - Vu Thao-Vi Dao AU - Martin Deile AU - Pavel I. Nedvetsky AU - Merlijn J. Meens AU - Andreas Güldner AU - César Ibarra-Alvarado AU - Axel Gödecke AU - Harald H.H.W. Schmidt Y1 - 2018/01/01 UR - http://biorxiv.org/content/early/2018/08/02/383208.abstract N2 - Endothelial nitric oxide (NO) stimulates the heme protein, soluble guanylyl cyclase (sGC) to form vasoprotective cyclic GMP (cGMP). In different disease states such as pulmonary hypertension, NO-cGMP signaling is pharmacologically augmented, yet the pathomechanisms leading to its dysregulation are incompletely understood. Here we show in pulmonary artery endothelial cells that endogenous NO or NO donor compounds acutely stimulate sGC activity, but chronically down-regulate both sGC protein and cGMP formation. Surprisingly, this endogenous feedback mechanism was independent of canonical cGMP signaling via cGMP-dependent protein kinase. It did not involve thiol-dependent modulation, a process relevant for sGC maturation, either. Rather tonic NO exposure led to inactivation and degradation of NO-sGC and without affecting NO-insensitive apo-sGC levels. Apo-sGC could be re-activated pharmacologically by the heme mimetic class of so-called sGC activators. Importantly, this non-canonical feedback was also observed in vivo. Specifically, it was induced by pathological high levels of NO in acute respiratory distress syndrome in which a similar self-limiting redox shift from NO-sensitive sGC to NO-insensitive apo-sGC occurred. Thus, our data establish a bimodal mechanism by which NO acutely stimulates sGC and chronically decreases sGC levels as part of a physiological and pathological self-limiting feedback. Of therapeutic importance in disease, our findings i) caution against any chronic use of classical NO donor drugs and ii) suggest that high NO-induced apo-sGC can be functionally fully recovered by sGC activator drugs to re-establish cGMP formation.Significance Statement Dysfunctional nitric oxide (NO) signaling via the cyclic GMP (cGMP) forming heme-protein soluble guanylate cyclase (sGC) is a key cardiopulmonary disease mechanism. However, in particular during chronic use, NO donor drugs display limited therapeutic benefit. Here we identify a previously unrecognized non-canonical chemical feedback mechanism, which selflimits cGMP formation in response to NO donor drugs and endogenous NO, both in health and disease. Whilst NO acutely stimulates sGC, we find that exposure of sGC to either chronic NO or pathological NO overproduction reduces sGC and generates heme-free apo-sGC which is insensitive to NO but sensitive to heme-mimetic sGC activators. Importantly, this chemical feedback explains the limited applicability of NO-donor drugs for chronic treatment and explain their mechanism-based indication in vascular disease conditions. ER -